Cargando…

Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition

Receptor tyrosine kinase (RTK) coexpression facilitates tumor resistance due to redundancies in the phosphatidylinositol-3′-kinase/protein kinase B and KRAS/extracellular-signal–regulated kinase signaling pathways, among others. Crosstalk between the oncogenic RTK hepatocyte growth factor receptor (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Patricia M.R., Norfleet, Jalen, Lewis, Jason S., Escorcia, Freddy E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Nuclear Medicine 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049345/ https://www.ncbi.nlm.nih.gov/pubmed/32646879 http://dx.doi.org/10.2967/jnumed.120.244897

Ejemplares similares

ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors
por: Escorcia, Freddy E., et al.
Publicado: (2020)

Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model
por: Escorcia, Freddy E., et al.
Publicado: (2018)

Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine
por: Schwark, Kallen, et al.
Publicado: (2022)

Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma
por: Yin, Xiang-Qian, et al.
Publicado: (2022)

PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
por: Rinne, Sara S., et al.
Publicado: (2021)

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
por: van Dongen, Guus A. M. S., et al.
Publicado: (2012)

Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology
por: Finotello, Francesca, et al.
Publicado: (2018)

Tumorigenicity of RTK/RAS in urothelium
por: Wu, Xue-Ru, et al.
Publicado: (2015)

Multi-GNSS PPP-RTK: From Large- to Small-Scale Networks
por: Nadarajah, Nandakumaran, et al.
Publicado: (2018)

Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field
por: Ledda, Fernanda, et al.
Publicado: (2007)

Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids
por: Gong, Ke, et al.
Publicado: (2021)

A Multi-Scale Anti-Multipath Algorithm for GNSS-RTK Monitoring Application
por: Wang, Shouhua, et al.
Publicado: (2023)

Targeting RTK Signaling Pathways in Cancer
por: Regad, Tarik
Publicado: (2015)

The trigger (and the restriction) of Torso RTK activation
por: Mineo, Alessandro, et al.
Publicado: (2018)

On the Problem of Double-Filtering in PPP-RTK
por: Khodabandeh, A., et al.
Publicado: (2022)

Immuno-Oncology: Emerging Targets and Combination Therapies
por: Marshall, Henry T., et al.
Publicado: (2018)

Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy
por: Shevtsov, Maxim, et al.
Publicado: (2019)

Will the Requirement by the US FDA to Simultaneously Co-Develop Companion Diagnostics (CDx) Delay the Approval of Receptor Tyrosine Kinase Inhibitors for RTK-Rearranged (ROS1-, RET-, AXL-, PDGFR-α-, NTRK1-) Non-Small Cell Lung Cancer Globally?
por: Ou, Sai-Hong Ignatius, et al.
Publicado: (2014)

Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights
por: Noelle, Randolph J., et al.
Publicado: (2023)

Immuno-PET Imaging to Assess Target Engagement: Experience from (89)Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors
por: Menke-van der Houven van Oordt, C. Willemien, et al.
Publicado: (2019)

Proteome-Wide Detection and Annotation of Receptor Tyrosine Kinases (RTKs): RTK-PRED and the TyReK Database
por: Filis, Georgios, et al.
Publicado: (2023)

Multi-GNSS-Weighted Interpolated Tropospheric Delay to Improve Long-Baseline RTK Positioning
por: Mirmohammadian, Farinaz, et al.
Publicado: (2022)

ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with (89)Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol
por: Hegi-Johnson, Fiona, et al.
Publicado: (2022)

Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling
por: Raquel-Cunha, Ana, et al.
Publicado: (2019)

Copper (II) Ions Activate Ligand-Independent Receptor Tyrosine Kinase (RTK) Signaling Pathway
por: He, Fang, et al.
Publicado: (2019)

Immuno-PET for Clinical Theranostic Approaches
por: Bailly, Clément, et al.
Publicado: (2016)

Glioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive Microenvironment
por: Hudson, Amanda L., et al.
Publicado: (2018)

Fault-Free Protection Level Equation for CLAS PPP-RTK and Experimental Evaluations
por: Kim, Euiho, et al.
Publicado: (2022)

RTK: efficient rarefaction analysis of large datasets
por: Saary, Paul, et al.
Publicado: (2017)

RTK Inhibitors in Melanoma: From Bench to Bedside
por: Sabbah, Malak, et al.
Publicado: (2021)

Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
por: Kamta, Jeff, et al.
Publicado: (2017)

ImmunoPET: Antibody-Based PET Imaging in Solid Tumors
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2022)

The Role of Radiation Oncology in Immuno‐Oncology
por: Meng, Xiangjiao, et al.
Publicado: (2019)

Systematic analysis of NLMP suggests nuclear localization of RTK/MET kinases resemble cancer cell clearance
por: Xie, Yingqiu, et al.
Publicado: (2019)

SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs
por: Belluomini, Lorenzo, et al.
Publicado: (2022)

Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer
por: Seidlitz, Therese, et al.
Publicado: (2022)

Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
por: Pereira, Patrícia M.R., et al.
Publicado: (2019)

Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET
por: Kim, Jin Su
Publicado: (2016)

Immuno-PET Molecular Imaging of RANKL in Cancer
por: Dewulf, Jonatan, et al.
Publicado: (2021)

Immuno-Imaging (PET/SPECT)–Quo Vadis?
por: Kramer, Carsten S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3g3nn5olh68th27nbp73dpgsjq